MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2023 International Congress

    Regional brain volume and cognitive alterations in Huntington’s Disease Patients

    M. Garon, L. Weis, L. Lerjefors, F. Pistonesi, V. Cianci, N. Cazzola, ML. Nasi, G. Bonato, D. Cecchin, M. Carecchio, A. Antonini, R. Biundo (padova, Italy)

    Objective: To investigate i) HD patterns of cortical and subcortical atrophies ii) associations between atrophy and clinical, motor and cognitive features. Background: Huntington’s disease (HD)…
  • 2023 International Congress

    Cognitive assessment of Parkinson’s disease carriers of the novel p.A30G mutation in the SNCA gene

    C. Koros, I. Alefanti, AM. Simitsi, A. Bougea, N. Papagiannakis, R. Antonelou, C. Kartanou, M. Bozi, I. Pachi, S. Varvaresos, A. Zahou, E. Stanitsa, M. Kodounis, M. Maniati, M. Panas, G. Paraskevas, S. Papageorgiou, C. Potagas, G. Karadima, G. Koutsis, L. Stefanis (Athens, Greece)

    Objective: The aim of the present report was to evaluate the cognitive profile of symptomatic Parkinson’s disease (PD) patients in a p.A30G SNCA genetic cohort.…
  • 2023 International Congress

    Proof-of-concept clinical trial: Prevent cognitive decline in GBA-associated Parkinson’s Disease

    K. Brockmann, JC. Corvol, A. Difonzo, S. Durrleman, T. Gasser, M. Hu, R. Krüger, I. Liepelt-Scarfone, M. Matarazzo, A. Pilotto, T. Simuni, P. Svenningsson, D. Weintraub, G. Pagano (Tuebingen, Germany)

    Objective: To prevent cognitive decline in GBA-associated Parkinson’s Disease (PD). Background: Dementia represents a key milestone in the course of PD with limited effective treatments…
  • 2023 International Congress

    Impact of Decreased Cognitive Function on the Risk of Falling in the Elderly

    R. Nindela, N. Sitohang, S. Marisdina (Palembang, Indonesia)

    Objective: This study aims to examine the correlation between cognitive function and the risk of falling in the elderly. Background: Falling is one of the…
  • 2023 International Congress

    Influence of Cognitive Function on Obstacle-Crossing Performance in People with Parkinson’s Disease: A Cross-Sectional Study

    HH. Hsu, RY. Wang, NC. Yeh, PL. Wong, CW. Hung (Taipei, Taiwan)

    Objective: This study investigated the influence of cognitive function on obstacle crossing performance in people with Parkinson's disease (PD). Background: Obstacle-crossing is a complex motor…
  • 2023 International Congress

    Comparison of cognitive , affective and autonomic functions in parkinson’s disease patients with and without freezing of gait and its correlation with PET/CT

    K. Harisankar, S. Mehta, R. Kumar, M. Mohanty, S. Singh, N. Balaini, V. Lal (CHANDIGARH, India)

    Objective: To study and compare the cognitive, affective and autonomic domains in Parkinson’s disease patients with and without freezing of gait and to correlate with…
  • 2023 International Congress

    Action- and emotion-related language abilities in Slovenian-speaking individuals with Parkinson’s disease – a background normative study

    ž. Drakulić Gorše, C. Manouilidou, M. Trošt (Ljubljana, Slovenia)

    Objective: To prepare action-related (AR) and emotion-related (ER) linguistic stimuli in Slovenian language to test language functions in Parkinson's disease (PD) patients. Background: PD patients…
  • 2023 International Congress

    Cognitive profile of essential tremor patients: Beyond the cerebellar cognitive affective syndrome

    A. Nasri, A. Rekik, S. Mrabet, Y. Abida, A. Souissi, A. Gharbi, I. Kacem, A. Gargouri, R. Gouider (Tunis, Tunisia)

    Objective: To describe the cognitive profile of essential tremor (ET) patients and gain insight into its pathophysiological process. Background: Nowadays, ET is considered as a…
  • 2023 International Congress

    Association between changes in hippocampal volumes, cognition, and CSF markers in Parkinson’s Disease

    S. Becker, O. Granert, C. Schulte, K. Brockmann, B. Roeben, M. Bode, M. Timmers, K. Scheffler, W. Maetzler, D. Berg, I. Liepelt-Scarfone (Calgary, Canada)

    Objective: To assess whether changes in hippocampal subfield volumes are associated with cognition or CSF β-amyloid 1–42 (Aβ42) levels in Parkinson’s Disease (PD). Background: Hippocampal…
  • 2023 International Congress

    Machine learning selects common fMRI features of cognitive impairment in Parkinson’s disease from cross-institution datasets

    CY. Chien, TY. Lin, TL. Lee, CCK. Lin (Tainan, Taiwan)

    Objective: To obtain common features of Parkinson's disease (PD) with cognitive impairment (CI) in resting-state functional MRI (rs-fMRI) from cross-institution datasets by adopting machine learning.…
  • « Previous Page
  • 1
  • …
  • 23
  • 24
  • 25
  • 26
  • 27
  • …
  • 128
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • #25179 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley